Prostate cancer Posts Page 2 on Medivizor
Navigation Menu

Prostate cancer Posts on Medivizor

Androgen deprivation therapy increases the risk of depression in patients with prostate cancer

Posted by on Dec 9, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to determine whether androgen deprivation therapy (ADT) is associated with an increased risk of depression for patients with prostate cancer. It found that there was an increased risk of depression.  Some background A main treatment option for prostate cancer is androgen deprivation therapy (ADT). This blocks...

Read More

Ability to reach orgasm following prostate surgery

Posted by on Dec 9, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine a patient’s ability to reach orgasm after robot-assisted laparoscopic prostatectomy (RALP) based on demographics, cancer-related and surgical variables, and erectile aids. The authors concluded that men could reach orgasm an average of 3 years after RALP. Poor orgasmic ability was associated with men...

Read More

Partial gland ablation versus prostate surgery in men with low- or intermediate-risk prostate cancer

Posted by on Nov 20, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine patient outcomes following partial gland ablation compared to robot-assisted radical prostate surgery in men with low- and intermediate- risk prostate cancer. The authors concluded that men with cancer confined to the prostate benefited from partial gland ablation, as it was more successful with fewer side...

Read More

Does Alcohol Increase Cancer Risk?

Does Alcohol Increase Cancer Risk?

Posted by on Nov 15, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

In July 2017, the American Society of Clinical Oncology (ASCO) conducted the National Cancer Opinion Survey to find out what people in the US know about cancer.  ASCO released the results in October.  The findings have already influenced recommendations made by the organization. Beliefs About Cancer Risk Among other questions, the survey asked  4,016...

Read More

New Studies Linking Gut Bacteria and Cancer Treatment

New Studies Linking Gut Bacteria and Cancer Treatment

Posted by on Nov 8, 2017 in Blog, Breast cancer, Colorectal cancer, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 2 comments

In It’s All In Your Gut, A High Fiber Diet and the Immune System, we introduced the microbiome that lives in our body.  It helps with our digestion and makes the short-chained fatty acids (SCFAs) that are important to our immune system.  Now several recent studies are looking at bacteria in the bodies of people with cancer.   Specifically, these...

Read More

An analysis of abiraterone plus prednisone for metastatic castration-resistant prostate cancer

Posted by on Nov 8, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to determine which patients  benefited most from abiraterone acetate (Zytiga) and prednisone (Deltasone). This study found that overall survival was increased for all patient groups that received this combination.  Some background A main treatment option for prostate cancer is androgen deprivation...

Read More

Minor impact of watchful waiting and active surveillance of localized prostate cancer on psychological well-being and quality of life.

Posted by on Nov 8, 2017 in Prostate cancer | 0 comments

In a nutshell This study investigated the impact monitoring an early stage prostate cancer had on quality of life or psychological state of mind. The study found that active surveillance or watchful waiting, instead of active treatment, has a minor impact on psychological and quality of life outcomes in the long-term. Some background Active...

Read More

What are the cardiovascular risks of surgical castration compared to hormone therapy?

Posted by on Oct 30, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to compare the risk of cardiovascular incidents (CIs, side-effects) of surgical castration versus castration achieved by hormone therapy. The study concluded that CIs were higher for surgical treatment at 1.5 years after treatment, but similar thereafter.  Some background For locally advanced or metastatic...

Read More

War on Cancer: The Right Metaphor?

War on Cancer: The Right Metaphor?

Posted by on Oct 22, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 8 comments

“For me, having lost my husband, it’s frustrating to hear publicly people saying to John McCain, ‘If anybody can beat this you can — you’re so tough.’  Not that it’s intentionally hurtful, but it does leave those of us who’ve lost a loved one thinking, ‘Was my loved one not tough enough? Did he not fight hard enough?'” ~Dannagal...

Read More

Prostate Cancer Awareness Month

Prostate Cancer Awareness Month

Posted by on Sep 26, 2017 in Blog, Prostate cancer | 2 comments

September is Prostate Cancer Awareness Month.  To increase awareness, Medivizor is sharing a theory from researchers at  Johns Hopkins University School of Medicine that attempts to explain what may be causing men in Europe and the US to be so vulnerable to prostate cancer. What does the prostate gland do? The prostate gland is part of the male...

Read More